Bovine Mastitis Treatment System Strategic Business Report 2024: Future Directions in Genomics and Breeding for Mastitis Resistance [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The "Bovine Mastitis Treatment System - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Bovine Mastitis Treatment System was estimated at US$1.8 Billion in 2023 and is projected to reach US$2.3 Billion by 2030, growing at a CAGR of 3.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Bovine mastitis treatment systems are revolutionizing dairy farming by providing targeted, efficient, and effective solutions to one of the most common and costly diseases affecting dairy cattle. Mastitis, an inflammation of the mammary gland, can significantly reduce milk production and quality, leading to substantial economic losses for dairy farmers. Advanced treatment systems are designed to diagnose and treat mastitis more quickly and accurately, helping to minimize the impact of
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges [Yahoo! Finance]Yahoo! Finance
- ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024GlobeNewswire
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024GlobeNewswire
ICCC
Sec Filings
- 11/13/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 10/8/24 - Form 8-K
- ICCC's page on the SEC website